Illinois Municipal Retirement Fund Decreases Holdings in Agilent Technologies, Inc. $A

Illinois Municipal Retirement Fund decreased its stake in Agilent Technologies, Inc. (NYSE:AFree Report) by 70.8% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 3,584 shares of the medical research company’s stock after selling 8,689 shares during the period. Illinois Municipal Retirement Fund’s holdings in Agilent Technologies were worth $460,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Capital A Wealth Management LLC raised its holdings in shares of Agilent Technologies by 10,600.0% in the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after purchasing an additional 212 shares during the period. Davis Capital Management purchased a new stake in Agilent Technologies in the third quarter worth $28,000. Physician Wealth Advisors Inc. raised its stake in shares of Agilent Technologies by 490.0% in the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after buying an additional 196 shares during the period. State of Wyoming bought a new stake in shares of Agilent Technologies in the second quarter valued at $35,000. Finally, SJS Investment Consulting Inc. lifted its position in shares of Agilent Technologies by 2,836.4% during the 3rd quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock valued at $41,000 after buying an additional 312 shares during the last quarter.

Insider Activity at Agilent Technologies

In related news, VP Rodney Gonsalves sold 3,000 shares of the business’s stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the transaction, the vice president owned 31,846 shares in the company, valued at $4,935,811.54. The trade was a 8.61% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Analyst Upgrades and Downgrades

A has been the topic of several recent research reports. Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and upped their price objective for the company from $155.00 to $160.00 in a report on Monday, January 5th. Morgan Stanley began coverage on shares of Agilent Technologies in a research report on Tuesday, December 2nd. They issued an “overweight” rating on the stock. The Goldman Sachs Group began coverage on shares of Agilent Technologies in a research note on Tuesday, December 9th. They set a “buy” rating and a $170.00 price target on the stock. Robert W. Baird raised their price objective on shares of Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a report on Tuesday, November 25th. Finally, Bank of America boosted their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a report on Tuesday, November 25th. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $164.50.

Get Our Latest Stock Report on Agilent Technologies

Agilent Technologies Stock Down 2.7%

A opened at $122.92 on Friday. The stock has a market cap of $34.77 billion, a PE ratio of 26.90, a P/E/G ratio of 3.67 and a beta of 1.30. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $160.27. The business’s fifty day simple moving average is $136.17 and its 200 day simple moving average is $135.61.

Agilent Technologies (NYSE:AGet Free Report) last issued its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The business had revenue of $1.86 billion during the quarter, compared to analyst estimates of $1.83 billion. During the same quarter in the prior year, the firm earned $1.46 earnings per share. Agilent Technologies’s revenue for the quarter was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio is 22.32%.

Agilent Technologies Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Further Reading

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.